Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients

Blood

Volumn 90, Issue 1, 1997, Pages 36-42

  Damiani, Daniela ^a   Fanin, Renato ^b   Silvestri, Federico ^b   Grimaz, Stefania ^b   Infanti, Laura ^b   Geromin, Antonella ^b   Cerno, Michela ^b   Michieli, Mariagrazia ^b   Rinaldi, Cristina ^b   Savignano, Chiara ^b   Trani, Gabriella ^b   Fiacchini, Mauro ^b   Baccarani, Michele ^b  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 8544263797     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.36     Document Type: Article

References (23)

1. Juttner CA: History of blood cell transplants, in Proceedings of the Fourth International Symposium on Blood Stem Cell Transplantation. Adelaide, South Australia, March 24-27, 1996, p 2
2. Sheridan SP, Begley CG, Juttner CA, Szer J, Bik To L, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
3. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi LM, Horning SJ, Brown SL, Miller L, Blume KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993
4. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, Storb R, Weaver C, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cell collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993
5. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353, 1996
6. Beyer J, Schwella N, Zigsen J, Strohscheer I, Schwaner I, Oettle H, Serke S, Huhn D, Siegert W: Hematopoietic rescue after high dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol 13:1328, 1995
7. Ogawa M, Ikebuchi K, Leary AG: Humoral regulation of stem cell proliferation. Ann NY Acad Sci 554:185, 1989
8. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S: Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol 22:100, 1994
9. Rinaldi C, Savignano C, Silvestri F, Geromin A, Cerno M, Biffoni F, Fanin R, Baccarani M: Autologous bone marrow transplantation in non-Hodgkin's lymphomas: Prediction of mononuclear cell yield in bone marrow harvests. Haematologica 80:443, 1995
10. Fanin R, Silvestri F, Geromin A, Cerno M, Infanti L, Zaja F, Barillari G, Savignano C, Rinaldi C, Damiani D, Buffoli A, Biffoni F, Baccarani M: Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: Sequential intensive treatment with the F-MACHOP regimen (± radiotherapy) and autologous bone marrow transplantation. Blood 87:1243, 1996
11. Ciavarella D: Hematopoietic stem cell processing and storage, in Goldstein J (ed): Biotechnology of Blood. Boston, MA, Buthlerworth-Heinemann, 1991, p 317
12. Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329, 1992
13. Geromin A, Fanin R, Silvestri F, Damiani D, Cerno M, Sperotto A, Savignano C, Rinaldi C, Baccarani M: Standard dose G-CSF (Filgrastim) after autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol 7: 179, 1996 (suppl 3)
14. Mandelli F, Annino L, Vegna ML, Camera A, Ciolli S, Deglano W, Fabiano F, Ferrara F, Ladogana S, Muti G, Peta A, Recchia A, Sica S, Stasi R, Tabilio A, Visani G, Baccarani M: GIMEMA ALL 0288: A multicentric study on adult acute lymphoblastic leukemia. Preliminary results. Leukemia 6:182, 1992 (suppl 2)
15. Guglielmi C, Amadori S, Anselmo AP, Baroni CD, Biagini C, Cimino G, Papa G, Mandelli F: Sequential combination chemotherapy of high-grade non-Hodgkin's lymphomas with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicine, vincristine and prednisone (F-MACHOP). Cancer Invest 5:159, 1987
16. Lord BI, Bronchud MH, Owens J, Chang J, Howell A, Souza L, Dexter TM: The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vitro. Proc Natl Acad Sci USA 86:9499, 1989
17. Johnsen HE, Hansen PB, Plesner T, Jensen L, Gaarsdal E, Andersen H, Hansen SW, Birgens H, Jacobsen GK, Kiaersgaard E, Hansen NE: Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant 10:229, 1992
18. Hansen PB, Knudsen H, Gaarsdal E, Jensen L, Ralfkiaer E, Johnsen HE: Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability. Bone Marrow Transplant 16:373, 1995
19. Janssen WE, Smilee RC, Elfenbein GJ: A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 4:139, 1995
20. Lowenthal RM, Sullivan SA, Parker N, Marsden KA: G-CSF-primed bone marrow cells for autologous transplantation. Lancet 347:1125, 1996
21. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074, 1988
22. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chaucey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner DC: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995
23. Henon P: Cost analysis of autologous blood cell transplantats, in Proceedings of the the Fourth International Symposium on Blood Stem Cell Transplantation. Adelaide, South Australia, March 24-27, 1996, p 42